Not less than-95.0%
13-Ethyl-3-ethynyl-18,19-dinor-17α-pregna-3,5-dien-20-yn-17-ol; (8R,9S,10R,13S,14S,17R)-13-Ethyl-3,17-diethynyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol; 3-Ethynyl levonorgestrel-3,5-diene; 13-Ethyl-3-ethynyl-18,19-dinor-17α-pregn-3,5-dien-20-yn-17-ol (As per USP Commenting Opening 51(3))